Polianta LTD Sage Therapeutics, Inc. Transaction History

Polianta LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$37.06 - $47.11 $941,324 - $1.2 Million	-25,400 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$40.26 - $57.37 $185,196 - $263,902	4,600 Added 22.12%	25,400 $1.13 Million
Q2 2021 Jul 06, 2021	BUY	$54.88 - $79.29 $301,840 - $436,095	5,500 Added 35.95%	20,800 $1.18 Million
Q1 2021 Apr 14, 2021	BUY	$70.65 - $96.76 $1.08 Million - $1.48 Million	15,300 New	15,300 $1.15 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $288M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.